Assignee
ACADEMISCH ZIEKENHUIS LEIDEN
NL·52 granted patents·62 pending applications·612 citations·filing 1985–2025
Top patents by PatentIndex Score
114 records- 0199US9499818B2Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy geneACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Granted Nov 22, 2016·61 cites·17 claims
- 0298US10190116B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Granted Jan 29, 2019·32 cites·21 claims
- 0398US8361979B2Means and method for inducing exon-skippingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2007·Granted Jan 29, 2013·142 cites·7 claims
- 0497US7534879B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2008·Granted May 19, 2009·142 cites·3 claims
- 0596US7973015B2Induction of exon skipping in eukaryotic cellsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2003·Granted Jul 5, 2011·157 cites·4 claims
- 0691US11820734B2Cathepsin inhibitorsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2021·Granted Nov 21, 2023·2 cites·23 claims
- 0789US10450356B2PRAME derived peptides and immunogenic compositions comprising theseACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Granted Oct 22, 2019·11 cites·17 claims
- 0887US11357836B2Prohemostatic proteins for the treatment of bleedingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Granted Jun 14, 2022·2 cites·4 claims
- 0987US10364432B2Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Jul 30, 2019·7 cites·4 claims
- 1086US11304995B2Prohemostatic proteins for the treatment of bleedingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Granted Apr 19, 2022·2 cites·9 claims
- 1186US11174224B2Cathepsin inhibitorsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2018·Granted Nov 16, 2021·3 cites·20 claims
- 1286US2024390467A1Prohemostatic proteins for the treatment of bleedingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2024·Application pending·0 cites
- 1385US11208657B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Granted Dec 28, 2021·0 cites·2 claims
- 1485US10544416B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2018·Granted Jan 28, 2020·1 cites·24 claims
- 1585US10078080B2Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Sep 18, 2018·2 cites·21 claims
- 1683US11458198B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2020·Granted Oct 4, 2022·1 cites·19 claims
- 1783US10258684B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Apr 16, 2019·3 cites·17 claims
- 1883US9764023B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Granted Sep 19, 2017·5 cites·18 claims
- 1981US12371400B2Cathepsin inhibitorsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2023·Granted Jul 29, 2025·0 cites·20 claims
- 2081US10537618B2Prohemostatic proteins for the treatment of bleedingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Granted Jan 21, 2020·3 cites·12 claims
- 2179US2023256075A1Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2022·Application pending·0 cites
- 2278US12083170B2Prohemostatic proteins for the treatment of bleedingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2022·Granted Sep 10, 2024·0 cites·11 claims
- 2378US10113165B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Granted Oct 30, 2018·1 cites·13 claims
- 2477US7202034B2Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responsesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2001·Granted Apr 10, 2007·12 cites·16 claims
- 2576US9562085B2Antimicrobial peptideACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Granted Feb 7, 2017·4 cites·13 claims
- 2675US2019241892A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 2774US2025093350A1Fab-linked glycans as biomarker for the transition from a pre disease "at-risk-phase" to rheumatoid arthritis, aav or sjögren syndromeACADEMISCH ZIEKENHUIS LEIDEN·Filed 2024·Application pending·0 cites
- 2874US2019225964A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2018·Application pending·0 cites
- 2972US10688173B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Granted Jun 23, 2020·0 cites·16 claims
- 3071US7993869B2Method for detecting glutenACADEMISCH ZIEKENHUIS LEIDEN·Filed 2005·Granted Aug 9, 2011·6 cites·20 claims
- 3171US2020110087A1Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 3270US2020332298A1Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 3370US2014378527A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 3470US2021405047A1Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2021·Application pending·0 cites
- 3569US9650423B2Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responsesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Granted May 16, 2017·1 cites·10 claims
- 3668US7807617B2Peptide inhibitors of toxins derived from LL-37ACADEMISCH ZIEKENHUIS LEIDEN·Filed 2004·Granted Oct 5, 2010·4 cites·11 claims
- 3768US2014357855A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 3868US2020224203A1Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2020·Application pending·0 cites
- 3968US2014357698A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 4067US10539563B2Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2018·Granted Jan 21, 2020·0 cites·15 claims
- 4167US2016355810A1Modulation of Exon Recognition in Pre-mRNA By Interfering with the Secondary RNA StructureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 4267US2017275624A1Methods of Inducing Exon SkippingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Application pending·0 cites
- 4367US2017268003A1Methods of Inducing Exon SkippingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Application pending·0 cites
- 4467US2013302806A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2012·Application pending·0 cites
- 4566US8029998B2Genetic markers for prognosis of antifolate treatment efficacyACADEMISCH ZIEKENHUIS LEIDEN·Filed 2008·Granted Oct 4, 2011·0 cites·6 claims
- 4665US10232081B2In situ tissue engineeringACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Granted Mar 19, 2019·1 cites·28 claims
- 4765US2009228998A1Induction of exon skipping in eukaryotic cellsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2009·Application pending·0 cites
- 4865US2016194636A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 4965US2016168570A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 5065US2016251658A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
Showing the top 50 of 114 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ACADEMISCH ZIEKENHUIS LEIDEN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →